Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;59(5):711-713.
doi: 10.1038/s41409-024-02253-y. Epub 2024 Feb 28.

How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration?

Yoann Grimaud  1 , Flore Sicre de Fontbrune  2 , David Michonneau  2   3 , Aude Desnoyer  1 , Régis Peffault de Latour  2 , Jérôme Larghero  1   4 , Justine Nasone  1   4 , Lionel Faivre  5   6
Affiliations

How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration?

Yoann Grimaud et al. Bone Marrow Transplant. 2024 May.
No abstract available

PubMed Disclaimer

References

    1. Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for blood and marrow transplantation. Biol Blood Marrow Transplant. 2015;21:1863–9. - DOI - PubMed - PMC
    1. Simonin M, Dalissier A, Labopin M, Willasch A, Zecca M, Mouhab A, et al. More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party. Bone Marrow Transplant. 2017;52:1071–3. - DOI - PubMed
    1. Bacigalupo A, Socié G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M, et al. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica. 2012;97:1142–8. - DOI - PubMed - PMC
    1. Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, et al. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. Lancet Oncol. 2016;17:164–73. - DOI - PubMed
    1. Gorin NC, Labopin M, Rocha V, Arcese W, Beksac M, Gluckman E, et al. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. Blood. 2003;102:3043–51. - DOI - PubMed

LinkOut - more resources